CONMED Corp. buy JPMorgan Chase & Co.
Start price
25.04.24
/
50%
€57.50
Target price
25.04.25
€69.92
Performance (%)
-23.13%
End price
26.04.25
€44.20
Summary
This prediction ended on 26.04.25 with a price of €44.20. The price of CONMED Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.13%. Dividends of €0.56 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | 0.461% | 0.461% | -4.386% |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $115.00 to $75.00. They now have an "overweight" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten